Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C (CHC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02864199
What this trial is testing

Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 63
Large-scale testing (Phase 3)Study completedNCT00304551
What this trial is testing

Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)

Who this might be right for
Liver CirrhosisChronic Hepatitis C
Chugai Pharmaceutical 180
Not applicableWithdrawnNCT03208322
What this trial is testing

Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in Adults

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT02806505
What this trial is testing

HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 81
Testing effectiveness (Phase 2)Study completedNCT01200420
What this trial is testing

Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects

Who this might be right for
Hepatitis C
Santaris Pharma A/S 38
Large-scale testing (Phase 3)Study completedNCT00411385
What this trial is testing

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3

Who this might be right for
Chronic Hepatitis C
Human Genome Sciences Inc. 933
Not applicableStudy completedNCT03063723
What this trial is testing

Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C (Disorder)
Third Affiliated Hospital, Sun Yat-Sen University 25
Post-approval studies (Phase 4)Ended earlyNCT00493805
What this trial is testing

Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303)

Who this might be right for
Hepatitis C, ChronicInsulin Resistance
Merck Sharp & Dohme LLC 59
Not applicableEnded earlyNCT01168856
What this trial is testing

An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 734
Not applicableStudy completedNCT00709059
What this trial is testing

Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 538
Post-approval studies (Phase 4)Active Not RecruitingNCT03520660
What this trial is testing

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Who this might be right for
Diabetes MellitusHepatitis C, ChronicCardiovascular Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 121
Not applicableUnknownNCT00188240
What this trial is testing

Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy

Who this might be right for
Hepatitis CHepatitis B
University Health Network, Toronto 200
Post-approval studies (Phase 4)Study completedNCT02641379
What this trial is testing

Peginterferon Alfa-2a (Pegasys) When Administered in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 737
Early research (Phase 1)Study completedNCT02014571
What this trial is testing

Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 37
Not applicableStudy completedNCT00687999
What this trial is testing

NIDDM and IR in Combination Therapy for CHC

Who this might be right for
Chronic Hepatitis CInsulin Resistance
Kaohsiung Medical University Chung-Ho Memorial Hospital 400
Large-scale testing (Phase 3)Ended earlyNCT02791256
What this trial is testing

Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 23
Not applicableUnknownNCT03887637
What this trial is testing

Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 180
Testing effectiveness (Phase 2)Study completedNCT03020004
What this trial is testing

Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China II

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 70
Testing effectiveness (Phase 2)Study completedNCT01726946
What this trial is testing

Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 10
Large-scale testing (Phase 3)Study completedNCT03020082
What this trial is testing

Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 141
Next Page